Skip to main content

Table 3 Reasons for Prescribing Sertindole Treatment

From: The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe

 

Number of patients (%)

Reasons

"Before" subgroup (n = 1,039)*

"After" subgroup (n = 393)**

Lack of efficacy of previous treatment

498 (49.0%)

222 (57.2%)

Adverse event under previous treatment

259 (25.5%)

73 (18.8%)

Patient desire to continue

146 (14.4%)

41 (10.6%)

Non compliance to previous treatment

74 (7.2%)

27 (7.0%)

Other reasons

40 (3.9%)

25 (6.4%)

Total

1,017 (100.0%)

388 (100.0%)

  1. * This group consisted of patients who started taking sertindole before the market suspension and who continued to take it during the suspension; information was missing for 22 patients
  2. ** This group consisted of patients who started taking sertindole during the market suspension; information was missing for 5 patients